These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2966113)

  • 1. Immunogenicity and side effects of low dose intradermally administered hepatitis B vaccine.
    Pathak UN; Dilawari JB; Chawla Y; Sokhey CS; Sharma BK; Ganguly NK
    Indian J Gastroenterol; 1988 Apr; 7(2):113-4. PubMed ID: 2966113
    [No Abstract]   [Full Text] [Related]  

  • 2. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH; Jones B; Dimitrakakis M; Mackay IR
    Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of intradermal hepatitis B immunization of hospital staff.
    McKee CM; Duke P; McEvoy MB; Kelsey MC
    Int J STD AIDS; 1990 Jan; 1(1):32-4. PubMed ID: 2151564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy.
    Redfield RR; Innis BL; Scott RM; Cannon HG; Bancroft WH
    JAMA; 1985 Dec; 254(22):3203-6. PubMed ID: 2933535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the immunogenicity of hepatitis B vaccine administered intradermally and intramuscularly.
    King JW; Taylor EM; Crow SD; White MC; Todd JR; Poe MB; Conrad SA; Gelder FB
    Rev Infect Dis; 1990; 12(6):1035-43. PubMed ID: 2148433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term observation of the effect of intradermal hepatitis B vaccination on mentally retarded patients.
    Hayashi J; Noguchi A; Nakashima K; Morofuji M; Kashiwagi S
    Eur J Epidemiol; 1991 Nov; 7(6):649-53. PubMed ID: 1838338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of low-dose intradermal hepatitis B vaccine.
    Rajadhyaksha KP; Haridas V; Plumber ST; Pipalia DH; Kamat RS; Abraham P; Naik SR
    Indian J Gastroenterol; 1988 Apr; 7(2):111. PubMed ID: 2966112
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose range study in healthy volunteers of a hepatitis B vaccine produced in yeast.
    Kuwert E; Scheiermann N; Gesemann M; Paar D; Safary A; Simoen E; Hauser P; Andre F
    Antiviral Res; 1985; Suppl 1():281-8. PubMed ID: 2935080
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA; Vuola JM; Valle M; von Reyn CF
    Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B--United States, 1990-1991.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Aug; 40(33):569-72. PubMed ID: 1830921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intradermal and intramuscular route for vaccination against hepatitis B.
    González ML; Usandizaga M; Alomar P; Salvá F; Martín F; Erroz MJ; Lardinois R
    Vaccine; 1990 Aug; 8(4):402-5. PubMed ID: 2144391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Specific safety and immunogenicity of a subunit vaccine against hepatitis B].
    Viazov SO; Vlasikhina EM; Margolina AN; Favorov MO; Poverennyĭ AM
    Vopr Virusol; 1985; 30(3):324-7. PubMed ID: 4049843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [H-B-VAX II hepatitis B vaccine (recombinant) produced at the MSD Research Laboratories. Description of the vaccine].
    Przegl Epidemiol; 1991; 45(1-2):3-10. PubMed ID: 1839076
    [No Abstract]   [Full Text] [Related]  

  • 15. [Active hepatitis B immunization--current status of development and effectiveness].
    Baumgarten R; Fengler JD
    Z Arztl Fortbild (Jena); 1986; 80(10):393-4. PubMed ID: 2944291
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody response after intradermal administration of recombinant hepatitis B vaccine in children.
    Wiström J; Gustafsson A
    Scand J Infect Dis; 1990; 22(5):621-2. PubMed ID: 2148015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Active preventive vaccination against hepatitis B].
    Jilg W
    Internist (Berl); 1985 Oct; 26(10):633-9. PubMed ID: 2934346
    [No Abstract]   [Full Text] [Related]  

  • 18. Two-year study of passive-active immunization for prevention of hepatitis B infection in newborns.
    Theppisai U; Thanuntaseh C; Chiewsilp P; Siripoonya P
    J Med Assoc Thai; 1988 Aug; 71(8):413-6. PubMed ID: 2978040
    [No Abstract]   [Full Text] [Related]  

  • 19. From the Centers for Disease Control. Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B--United States, 1990-1991.
    JAMA; 1991 Sep; 266(10):1338-9. PubMed ID: 1831865
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity of hepatitis B vaccine in Chinese school children: a comparison of two plasma-derived vaccines.
    Lee SD; Lo KJ; Tsai YT; Chan CY; Wu TC; Hwang SJ; Chang CP; Huang YS
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Aug; 42(2):87-92. PubMed ID: 3066454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.